Title 21

PART 54

Part 54 - Financial Disclosure By Clinical Investigators

PART 54 - FINANCIAL DISCLOSURE BY CLINICAL INVESTIGATORS Authority:21 U.S.C. 321, 331, 351, 352, 353, 355, 360, 360c-360j, 371, 372, 373, 374, 375, 376, 379; 42 U.S.C. 262. Source:63 FR 5250, Feb. 2, 1998, unless otherwise noted.

• Authority: 21 U.S.C. 321, 331, 351, 352, 353, 355, 360, 360c-360j, 371, 372, 373, 374, 375, 376, 379; 42 U.S.C. 262.
• Source: 63 FR 5250, Feb. 2, 1998, unless otherwise noted.

21:1.0.1.1.22.0.63.1	SECTION 54.1	54.1 Purpose.
21:1.0.1.1.22.0.63.2	SECTION 54.2	54.2 Definitions.
21:1.0.1.1.22.0.63.3	SECTION 54.3	54.3 Scope.
21:1.0.1.1.22.0.63.4	SECTION 54.4	54.4 Certification and disclosure requirements.
21:1.0.1.1.22.0.63.5	SECTION 54.5	54.5 Agency evaluation of financial interests.
21:1.0.1.1.22.0.63.6	SECTION 54.6	54.6 Recordkeeping and record retention.

---